[1]
|
Dong, G., Yang, Y., Li, X., Yao, X., Zhu, Y., Zhang, H., Wang, H., Ma, Q., Zhang, J., Shi, H., Ning, Z., Yan, F., Zhai, W., Dai, J., Li, Z., Li, C., Ming, J., Xue, Q., Meng, X., Si, C. and Xiong, H. (2020) Granulocytic Myeloid-Derived Suppressor Cells Contribute to IFN-I Signaling Activation of B Cells and Disease Progression through the lncRNA NEAT1-BAFF Axis in Systemiclupus Erythematosus. Biochimica et Biophysica Acta—Molecular Basis of Disease, 1866, Article ID: 165554. https://doi.org/10.1016/j.bbadis.2019.165554
|
[2]
|
Tsai, C.Y., Li, K.J., Hsieh, S.C., Liao, H.T. and Yu, C.L. (2019) What’s Wrong with Neutrophils in Lupus? Clinical and Experimental Rheumatology, 37, 684-693.
|
[3]
|
Tsai, C.Y., Hsieh, S.C., Lu, C.S., Wu, T.H., Liao, H.T., Wu, C.H., Li, K.J., Kuo, Y.M., Lee, H.T., Shen, C.Y. and Yu, C.L. (2019) Cross-Talk between Mitochondrial Dysfunction Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE. International Journal of Molecular Sciences, 20, Article 5183. https://doi.org/10.3390/ijms20205183
|
[4]
|
Kaul, A., Gordon, C., Crow, M.K., Touma, Z., Urowitz, M.B., van Vollenhoven, R., et al. (2016) Systemic Lupus Erythematosus. Nature Reviews Disease Primers, 2, Article No. 16039. https://doi.org/10.1038/nrdp.2016.39
|
[5]
|
Mahieu, M.A., Strand, V., Simon, L.S., Lipsky, P.E. and Ramsey-Goldman, R. (2016) A Critical Review of Clinical Trials in Systemic Lupus Erythematosus. Lupus, 25, 1122-1140. https://doi.org/10.1177/0961203316652492
|
[6]
|
Mashouri, L., Yousefifi, H., Aref, A.R., Ahadi, A.M., Molaei, F. and Alahari, S.K. (2019) Exosomes: Composition, Biogenesis, and Mechanisms in Cancer Metastasis and Drug Resistance. Molecular Cancer, 18, Article No. 75.
https://doi.org/10.1186/s12943-019-0991-5
|
[7]
|
Rayamajhi, S., Nguyen, T.D.T., Marasini, R. and Aryal, S. (2019) Macrophage-Derived Exosome-Mimetic Hybrid Vesicles for Tumor Targeted Drug Delivery. Acta Biomaterialia, 94, 482-494.
https://doi.org/10.1016/j.actbio.2019.05.054
|
[8]
|
Tan, L., Wu, H., Liu, Y., Zhao, M., Li, D. and Lu, Q. (2016) Recent Advances of Exosomes in Immune Modulation and Autoimmune Diseases. Autoimmunity, 49, 357-365. https://doi.org/10.1080/08916934.2016.1191477
|
[9]
|
Pegtel, D.M. and Gould, S.J. (2019) Exosomes. Annual Re-view of Biochemistry, 88, 487-514.
https://doi.org/10.1146/annurev-biochem-013118-111902
|
[10]
|
Thery, C., Zitvogel, L. and Amigorena, S. (2002) Exosomes: Composition, Biogenesis and Function. Nature Reviews Immunology, 2, 569-579. https://doi.org/10.1038/nri855
|
[11]
|
Cosenza, S., Toupet, K., Maumus, M., Luz-Crawford, P., Blanc-Brude, O., Jorgensen, C. and Noël, D. (2018) Mesenchymal Stem Cells-Derived Exosomes Are More Immunosuppressive than Microparticles in Inflammatory Arthritis. Theranostics, 8, 1399-1410. https://doi.org/10.7150/thno.21072
|
[12]
|
Mathieu, M., Martin-Jaular, L., Lavieu, G. and Théry, C. (2019) Speci-ficities of Secretion and Uptake of Exosomes and Other Extracellular Vesicles for Cell-to-Cell Communication. Nature Cell Biology, 21, 9-17.
https://doi.org/10.1038/s41556-018-0250-9
|
[13]
|
Nath, S., Agholme, L., Kurudenkandy, F.R., Granseth, B., Marcusson, J. and Hallbeck, M. (2012) Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid. Journal of Neuroscience, 32, 8767-8777.
https://doi.org/10.1523/JNEUROSCI.0615-12.2012
|
[14]
|
Arellano-Anaya, Z.E., Huor, A., Leblanc, P., Lehmann, S., Provansal, M., Raposo, G., et al. (2015) Prion Strains Are Differentially Released through the Exosomal Pathway. Cellular and Molecular Life Sciences, 72, 1185-1196.
https://doi.org/10.1007/s00018-014-1735-8
|
[15]
|
Lööv, C., Scherzer, C.R., Hyman, B.T., Breakefifield, X.O. and Ingelsson, M. (2016) α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities. Cellular and Molecular Neurobiology, 36, 437-448.
https://doi.org/10.1007/s10571-015-0317-0
|
[16]
|
徐莹, 周茹, 张欣洲, 等. SLE患者血清外泌体环状RNA的差异表达分析[J]. 湖北科技学院学报(医学版), 2022, 36(2): 129-133, 137. https://doi.org/10.16751/j.cnki.2095-4646.2022.02.129
|
[17]
|
Long, H., Wang, X., Chen, Y., Wang, L., Zhao, M. and Lu, Q. (2018) Dysregulation of microRNAs in Autoimmune Diseases: Pathogenesis, Biomarkers and Potential Therapeutic Targets. Cancer Letters, 428, 90-103.
https://doi.org/10.1016/j.canlet.2018.04.016
|
[18]
|
Perez-Hernandez, J., Redon, J. and Cortes, R. (2017) Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus. International Journal of Molecular Sciences, 18, Article 717. https://doi.org/10.3390/ijms18040717
|
[19]
|
Perez-Hernandez, J., Martinez-Arroyo, O., Ortega, A., Galera, M., Solis-Salguero, M.A., Chaves, F.J., Redon, J., Forner, M.J. and Cortes, R. (2021) Urinary Exosomal miR-146a as a Marker of Albuminuria, Activity Changes and Disease Flares in Lupus Nephritis. Journal of Nephrology, 34, 1157-1167. https://doi.org/10.1007/s40620-020-00832-y
|
[20]
|
Dong, C., Zhou, Q., Fu, T., Zhao, R., Yang, J., Kong, X., Zhang, Z., Sun, C., Bao, Y., Ge, X., Zhang, Z., Lu, Z., Li, J., Zheng, W., Gu, Z. and Ji, J. (2019) Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells. BioMed Research International, 2019, Article ID: 6071308.
https://doi.org/10.1155/2019/6071308
|
[21]
|
Li, W., Liu, S., Chen, Y., Weng, R., Zhang, K., He, X. and He, C. (2020) Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus. Clinics (Sao Paulo), 75, e1528. https://doi.org/10.6061/clinics/2020/e1528
|
[22]
|
Huang, Y., Li, R., Ye, S., Lin, S., Yin, G. and Xie, Q. (2020) Recent Advances in the Use of Exosomes in Sjögren’s Syndrome. Frontiers in Immunology, 11, Article 1509. https://doi.org/10.3389/fimmu.2020.01509
|
[23]
|
Wu, J.Y., Li, Y.J., Hu, X.B., Huang, S. and Xiang, D.X. (2021) Preservation of Small Extracellular Vesicles for Functional Analysis and Therapeutic Applications: A Comparative Evaluation of Storage Conditions. Drug Delivery, 28, 162-170. https://doi.org/10.1080/10717544.2020.1869866
|
[24]
|
Yang, D., Zhang, W., Zhang, H., et al. (2020) Progress, Opportunity, and Perspective on Exosome Isolation—Efforts for efficient Exosome-Based Theranostics. Theranostics, 10, 3684-3707. https://doi.org/10.7150/thno.41580
|
[25]
|
Duan, L., Xu, L., Xu, X., et al. (2021) Exosome-Mediated Delivery of Gene Vectors for Gene Therapy. Nanoscale, 13, 1387-1397. https://doi.org/10.1039/D0NR07622H
|
[26]
|
Peng, H., Ji, W., Zhao, R., Yang, J., Lu, Z., Li, Y. and Zhang, X. (2020) Exosome: A Significant Nanoscale Drug Delivery Carrier. Journal of Materials Chemistry B, 8, 7591-7608. https://doi.org/10.1039/D0TB01499K
|
[27]
|
Elliott, R.O. and He, M. (2021) Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery. Pharmaceutics, 13, Article 122. https://doi.org/10.3390/pharmaceutics13010122
|
[28]
|
Gutierrez-Millan, C., Calvo Díaz, C., Lanao, J.M. and Colino, C.I. (2021) Advances in Exosomes-Based Drug Delivery Systems. Macromolecular Bioscience, 21, e2000269. https://doi.org/10.1002/mabi.202000269
|
[29]
|
Kim, H., Jang, H., Cho, H., et al. (2021) Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy. Cancers, 13, Article 4435. https://doi.org/10.3390/cancers13174435
|